Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag Five months after BC's premier called for reforms to its costly rare disease drug program, no changes have been made, leaving patients without reliable access.

flag Five months after British Columbia’s premier called for reforms to its high-cost rare disease drug program, no concrete changes have been made. flag The program, intended to provide life-saving treatments, continues to face delays, inconsistent approvals, and limited transparency. flag Patients and advocates report ongoing struggles with access and affordability, despite some temporary solutions. flag Health officials acknowledge challenges in balancing cost and care but have not announced a timeline for reforms, leaving families in uncertainty.

3 Articles